| Product NDC: | 67877-291 | 
| Proprietary Name: | Hydralazine Hydrochloride | 
| Non Proprietary Name: | Hydralazine Hydrochloride | 
| Active Ingredient(s): | 50 mg/1 & nbsp; Hydralazine Hydrochloride | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 67877-291 | 
| Labeler Name: | Ascend Laboratories, LLC | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA200737 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20091124 | 
| Package NDC: | 67877-291-10 | 
| Package Description: | 1000 TABLET in 1 BOTTLE (67877-291-10) | 
| NDC Code | 67877-291-10 | 
| Proprietary Name | Hydralazine Hydrochloride | 
| Package Description | 1000 TABLET in 1 BOTTLE (67877-291-10) | 
| Product NDC | 67877-291 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Hydralazine Hydrochloride | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20091124 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Ascend Laboratories, LLC | 
| Substance Name | HYDRALAZINE HYDROCHLORIDE | 
| Strength Number | 50 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Arteriolar Vasodilation [PE],Arteriolar Vasodilator [EPC] |